EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Circulating extracellular vesicles in human cardiorenal syndrome promote renal injury in a kidney-on-chip system

Emeli Chatterjee, Rodosthenis S Rodosthenous, Ville Kujala, Priyanka Gokulnath, Michail Spanos, Helge Immo Lehmann, Getulio Pereira de Oliveira, Mingjian Shi, Tyne W Miller-Fleming, Guoping Li, Ionita Calin Ghiran, Katia Karalis und 7 weitere

JCI Insight · 22.11.2023 · 8 (22)

DOI: 10.1172/jci.insight.165172 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JCI Insight, online erschienen am 22.11.2023. Verfasst von Emeli Chatterjee und 18 weiteren Autor:innen. Beteiligte Einrichtung: Cardiovascular Research Center, Massachusetts General Hospital, Boston, Massachusetts, USA. Hauptthemen laut MEDLINE: Cardio-Renal Syndrome, MicroRNAs, Extracellular Vesicles, Heart Failure. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 87 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS, NCATS NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND Cardiorenal syndrome (CRS) — renal injury during heart failure (HF) — is linked to high morbidity. Whether circulating extracellular vesicles (EVs) and their RNA cargo directly impact its pathogenesis remains unclear. METHODS We investigated the role of circulating EVs from patients with CRS on renal epithelial/endothelial cells using a microfluidic kidney-on-chip (KOC) model. The small RNA cargo of circulating EVs was regressed against serum creatinine to prioritize subsets of functionally relevant EV-miRNAs and their mRNA targets investigated using in silico pathway analysis, human genetics, and interrogation of expression in the KOC model and in renal tissue. The functional effects of EV-RNAs on kidney epithelial cells were experimentally validated. RESULTS Renal epithelial and endothelial cells in the KOC model exhibited uptake of EVs from patients with HF. HF-CRS EVs led to higher expression of renal injury markers (IL18, LCN2, HAVCR1) relative to non-CRS EVs. A total of 15 EV-miRNAs were associated with creatinine, targeting 1,143 gene targets specifying pathways relevant to renal injury, including TGF-β and AMPK signaling. We observed directionally consistent changes in the expression of TGF-β pathway members (BMP6, FST, TIMP3) in the KOC model exposed to CRS EVs, which were validated in epithelial cells treated with corresponding inhibitors and mimics of miRNAs. A similar trend was observed in renal tissue with kidney injury. Mendelian randomization suggested a role for FST in renal function. CONCLUSION Plasma EVs in patients with CRS elicit adverse transcriptional and phenotypic responses in a KOC model by regulating biologically relevant pathways, suggesting a role for EVs in CRS. TRIAL REGISTRATION ClinicalTrials.gov NCT03345446. FUNDING American Heart Association (AHA) (SFRN16SFRN31280008); National Heart, Lung, and Blood Institute (1R35HL150807-01); National Center for Advancing Translational Sciences (UH3 TR002878); and AHA (23CDA1045944)

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cardio-Renal SyndromeMicroRNAsExtracellular VesiclesHeart FailureHumansEndothelial CellsKidneyTransforming Growth Factor beta

Stichwörter der Autor:innen

CardiologyFibrosisHeart failureNephrologyNoncoding RNAs

Substanzen

MicroRNAsTransforming Growth Factor beta

Autor:innen und Institutionen

  • Cardiovascular Research Center, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Institute for Molecular Medicine Finland, Helsinki Institute of Life Science, University of Helsinki, Helsinki, Finland.
  • Emulate, Inc., Boston, Massachusetts, USA.
  • Department of Anesthesia, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.
  • Department of Biomedical Informatics and.
  • Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA.

Förderung

  • NHLBI NIH HHS
  • NCATS NIH HHS
  • National Institutes of Health
  • American Heart Association

Zitieren

APA

Chatterjee, E., Rodosthenous, R. S., Kujala, V., Gokulnath, P., Spanos, M., Lehmann, H. I., de Oliveira, G. P., Shi, M., Miller-Fleming, T. W., Li, G., Ghiran, I. C., Karalis, K., Lindenfeld, J., Mosley, J. D., Lau, E. S., Ho, J. E., Sheng, Q., Shah, R., & Das, S. (2023). Circulating extracellular vesicles in human cardiorenal syndrome promote renal injury in a kidney-on-chip system. JCI Insight, 8(22). https://doi.org/10.1172/jci.insight.165172

Vancouver

Chatterjee E, Rodosthenous RS, Kujala V, Gokulnath P, Spanos M, Lehmann HI, et al. Circulating extracellular vesicles in human cardiorenal syndrome promote renal injury in a kidney-on-chip system. JCI Insight. 2023;8(22). doi:10.1172/jci.insight.165172

BibTeX
@article{Chatterjee2023,
  author = {Chatterjee, Emeli and Rodosthenous, Rodosthenis S and Kujala, Ville and Gokulnath, Priyanka and Spanos, Michail and Lehmann, Helge Immo and de Oliveira, Getulio Pereira and Shi, Mingjian and Miller-Fleming, Tyne W and Li, Guoping and Ghiran, Ionita Calin and Karalis, Katia and Lindenfeld, JoAnn and Mosley, Jonathan D and Lau, Emily S and Ho, Jennifer E and Sheng, Quanhu and Shah, Ravi and Das, Saumya},
  title = {Circulating extracellular vesicles in human cardiorenal syndrome promote renal injury in a kidney-on-chip system},
  journal = {JCI Insight},
  year = {2023},
  volume = {8},
  number = {22},
  doi = {10.1172/jci.insight.165172}
}
Kostenlos starten →